1	Lung cancer	Erlotinib	Approved	Crizotinib	 Approved	Cisplatin	Approved
2	Breast cancer	Tamoxifen	Approved	Trastuzumab	 Approved	Methotrexate	Approved
3	Leukemia	Imatinib	Approved	Rituximab	 Approved	Methotrexate	Approved
4	Prostate cancer	Enzalutamide	Approved	Cyclophosphamide	 Under trials	Prednisone	Approved
5	Colorectal cancer	Fluorouracil	Approved	Irinotecan	 Approved	Bevacizumab	Approved
6	Brain tumor	Temozolomide	Approved	Dexamethasone	 Non approved 	Aminolevulinic acid	Under trials
7	Pancreatic cancer	Fluorouracil	Approved	Gemcitabine	 Approved	Protein-bound paclitaxel	Approved
8	Melanoma	Vemurafenib	Approved	Dabrafenib	 Approved	Trametinib	Approved
9	Stomach cancer	Trastuzumab	Approved	Doxorubicin	 Approved	Cisplatin	Under trials
10	Ovarian cancer	Cisplatin	Approved	Tamoxifen	 Under trials	Bevacizumab	Approved
11	Cervical cancer	HPV vaccines	Approved	Cisplatin	 Approved	Topotecan	Approved
12	Hodgkin's lymphoma	Prednisone	Approved	Cyclophosphamide	 Approved	Vincristine	Approved
13	Skin cancer	Vemurafenib	Approved	Dabrafenib	 Approved	Fluorouracil	Approved
14	Multiple myeloma	Dexamethasone	Under trials	Elotuzumab	 Approved	Bortezomib	Approved
15	Esophageal cancer	Cisplatin	Approved	Carboplatin	 Approved	Fluorouracil	Approved
16	Liver cancer	Doxorubicin	Under trials	Cisplatin	 Under trials	Sorafenib	Approved
17	Non-Hodgkin's lymphoma	Cyclophosphamide	Approved	Rituximab	 Approved	Prednisone	Approved
18	Bladder cancer	Doxorubicin	Approved	Cisplatin	 Approved	Methotrexate	Approved
19	Head and neck cancer	Cetuximab	Approved	Paclitaxel	 Approved	Cisplatin	Approved
20	Testicular cancer	Etoposide	Approved	Cisplatin	 Approved	Bleomycin	Approved